These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 21631264)

  • 1. Molecular signatures of pancreatic cancer.
    Hong SM; Park JY; Hruban RH; Goggins M
    Arch Pathol Lab Med; 2011 Jun; 135(6):716-27. PubMed ID: 21631264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential methylation landscape of pancreatic ductal adenocarcinoma and its precancerous lesions.
    Bararia A; Dey S; Gulati S; Ghatak S; Ghosh S; Banerjee S; Sikdar N
    Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):205-217. PubMed ID: 32312637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classification, Morphology, Molecular Pathogenesis, and Outcome of Premalignant Lesions of the Pancreas.
    Pittman ME; Rao R; Hruban RH
    Arch Pathol Lab Med; 2017 Dec; 141(12):1606-1614. PubMed ID: 29189063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular pathogenesis of precursor lesions of pancreatic ductal adenocarcinoma.
    Biankin AV; Kench JG; Dijkman FP; Biankin SA; Henshall SM
    Pathology; 2003 Feb; 35(1):14-24. PubMed ID: 12701679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precursor lesions of pancreatic cancer: molecular pathology and clinical implications.
    Singh M; Maitra A
    Pancreatology; 2007; 7(1):9-19. PubMed ID: 17449961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathology of Pancreatic Cancer Precursor Lesions.
    Noë M; Brosens LA
    Surg Pathol Clin; 2016 Dec; 9(4):561-580. PubMed ID: 27926360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precursor lesions in pancreatic cancer: morphological and molecular pathology.
    Scarlett CJ; Salisbury EL; Biankin AV; Kench J
    Pathology; 2011 Apr; 43(3):183-200. PubMed ID: 21436628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on the pathology and genetics of exocrine pancreatic tumors with ductal phenotype: precursor lesions and new tumor entities.
    Lüttges J; Klöppel G
    Dig Dis; 2001; 19(1):15-23. PubMed ID: 11385247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphogenesis of pancreatic cancer: role of pancreatic intraepithelial neoplasia (PanINs).
    Koorstra JB; Feldmann G; Habbe N; Maitra A
    Langenbecks Arch Surg; 2008 Jul; 393(4):561-70. PubMed ID: 18283486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia.
    Ozaki N; Ohmuraya M; Ida S; Hashimoto D; Ikuta Y; Chikamoto A; Hirota M; Baba H
    J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):620-7. PubMed ID: 23475261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pathology of intraductal papillary mucinous neoplasms of the pancreas.
    Paini M; Crippa S; Partelli S; Scopelliti F; Tamburrino D; Baldoni A; Falconi M
    World J Gastroenterol; 2014 Aug; 20(29):10008-23. PubMed ID: 25110429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From somatic mutation to early detection: insights from molecular characterization of pancreatic cancer precursor lesions.
    Fischer CG; Wood LD
    J Pathol; 2018 Dec; 246(4):395-404. PubMed ID: 30105857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Precursor lesions of pancreatobiliary cancer].
    Sipos B; Henopp T
    Pathologe; 2011 Nov; 32 Suppl 2():224-31. PubMed ID: 21909795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intraepithelial neoplasms (PanIN) and intraductal papillary-mucinous neoplasms (IPMN) of the pancreas as precursor lesions of pancreatic carcinoma].
    Ott C; Heinmöller E; Gaumann A; Schölmerich J; Klebl F
    Med Klin (Munich); 2007 Feb; 102(2):127-35. PubMed ID: 17323019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects.
    Adsay NV; Basturk O; Cheng JD; Andea AA
    Semin Radiat Oncol; 2005 Oct; 15(4):254-64. PubMed ID: 16183479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precursor lesions for sporadic pancreatic cancer: PanIN, IPMN, and MCN.
    Distler M; Aust D; Weitz J; Pilarsky C; Grützmann R
    Biomed Res Int; 2014; 2014():474905. PubMed ID: 24783207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precursors to invasive pancreatic cancer.
    Maitra A; Fukushima N; Takaori K; Hruban RH
    Adv Anat Pathol; 2005 Mar; 12(2):81-91. PubMed ID: 15731576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathologic aspects of intraductal papillary-mucinous neoplasm and pancreatic intraepithelial neoplasia--their associations with carcinogenesis.
    Furukawa T
    Nihon Shokakibyo Gakkai Zasshi; 2007 Sep; 104(9):1329-37. PubMed ID: 17827903
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular pathways in pancreatic carcinogenesis.
    Macgregor-Das AM; Iacobuzio-Donahue CA
    J Surg Oncol; 2013 Jan; 107(1):8-14. PubMed ID: 22806689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic Ductal Adenocarcinoma and Its Precursor Lesions: Histopathology, Cytopathology, and Molecular Pathology.
    Ren B; Liu X; Suriawinata AA
    Am J Pathol; 2019 Jan; 189(1):9-21. PubMed ID: 30558727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.